Thu 4/2/2020 16:13 ET
DJIA21413.44479.662.24%TELCO161.165.463.39%GOLD1638.8047.362.89%Shanghai2780.6446.991.69%
S&P 5002526.4757.352.27%BANKS291.968.472.90%OIL25.024.7118.82%BITCOIN6763.05120.381.78%
NASDAQ7487.31128.781.72%PHARM554.3818.743.38%US/EU1.090.000.01%Futures2523.3875.452.99%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Neurocrine Biosciences - NBIX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NBIX
  
From: AnthonyJackson (Rep: 0)Date: 01/18/2017 09:43
Forum: Neurocrine Biosciences - Msg #1113Thread #673900131 (Rec: 0)
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are trading lower by over 5% after the company announced disappointing phase II results for INGREZZA, a highly-selective small molecule Vesicular Monoamine Transporter 2 (VMAT2) inhibitor. Analysts are scrambling to find the proper price target and buy levels. Based on extensive stock chart analysis, the first major support level is at $32.75 The current stock price is $38.00. This will be a buy level for investors looking to pick up Neurocrine Biosciences on the cheap for a swing trade.
Stock market investors buy the Neurocrine Biosciences chart

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser AnthonyJackson: Reward | Watch | IgnoreNBIX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NBIX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.